X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-03-20 | RNA | Flanagan W. Michael | Chief Scientific Officer | S - Sale | $31.06 | -11,780 | 80,195 | -13% | -$365,868 | ||||||
| D | 2025-03-11 | RNA | Flanagan W. Michael | Chief Scientific Officer | S - Sale+OE | $30.13 | -20,000 | 91,975 | -18% | -$602,614 | |||||
2025-01-21 | RNA | Flanagan W. Michael | Chief Scientific Officer | S - Sale | $28.60 | -5,672 | 91,975 | -6% | -$162,192 | ||||||
2024-12-18 | RNA | Flanagan W. Michael | CSTO | S - Sale | $32.66 | -12,742 | 72,647 | -15% | -$416,154 | ||||||
| D | 2024-12-11 | RNA | Flanagan W. Michael | CSTO | S - Sale+OE | $35.77 | -24,000 | 85,389 | -22% | -$858,401 | |||||
| D | 2024-10-01 | RNA | Flanagan W. Michael | CSTO | S - Sale+OE | $47.62 | -62,500 | 85,389 | -42% | -$2,976,113 | |||||
2024-09-23 | RNA | Flanagan W. Michael | CSTO | S - Sale | $43.95 | -25,000 | 85,389 | -23% | -$1,098,733 | ||||||
| D | 2024-09-11 | RNA | Flanagan W. Michael | CSTO | S - Sale+OE | $40.40 | -111,394 | 60,871 | -65% | -$4,500,244 | |||||
2024-06-18 | RNA | Flanagan W. Michael | CSTO | S - Sale | $39.13 | -10,106 | 75,765 | -12% | -$395,445 | ||||||
| D | 2024-01-22 | RNA | Flanagan W. Michael | CSTO | S - Sale+OE | $10.13 | -4,129 | 35,871 | -10% | -$41,827 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |